ID   STM91-01
AC   CVCL_8000
SY   STM-91-01; STM9101
DR   BioSample; SAMN10989622
DR   Cell_Model_Passport; SIDM01860
DR   Cosmic; 801777
DR   Cosmic; 1063889
DR   Cosmic; 2144788
DR   DepMap; ACH-001200
DR   GEO; GSM2033129
DR   GEO; GSM2033130
DR   GEO; GSM2033131
DR   GEO; GSM2033132
DR   GEO; GSM2033133
DR   GEO; GSM2033134
DR   TOKU-E; 4152
DR   Wikidata; Q54970600
RX   PubMed=8385567;
RX   PubMed=8818656;
RX   PubMed=9559292;
RX   PubMed=9920784;
RX   PubMed=11557780;
RX   PubMed=11921280;
RX   PubMed=12210830;
RX   PubMed=16557275;
RX   PubMed=24418192;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Gene deletion; HGNC; 11103; SMARCB1; Zygosity=Homozygous (PubMed=11921280).
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): DepMap=ACH-001200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D18S51: 12,17
ST   D21S11: 29,31
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 11
ST   D8S1179: 10,15
ST   FGA: 22,26
ST   Penta D: 10,17
ST   Penta E: 5,16
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 21
//
RX   PubMed=8385567; DOI=10.1002/1097-0142(19930501)71:9<2862::AID-CNCR2820710930>3.0.CO;2-D;
RA   Ota S., Crabbe D.C.G., Tran T.N., Triche T.J., Shimada H.;
RT   "Malignant rhabdoid tumor. A study with two established cell lines.";
RL   Cancer 71:2862-2872(1993).
//
RX   PubMed=8818656; DOI=10.1002/(SICI)1098-2264(199606)16:2<94::AID-GCC3>3.0.CO;2-Y;
RA   Biegel J.A., Allen C.S., Kawasaki K., Shimizu N., Budarf M.L.,
RA   Bell C.J.;
RT   "Narrowing the critical region for a rhabdoid tumor locus in 22q11.";
RL   Genes Chromosomes Cancer 16:94-105(1996).
//
RX   PubMed=9559292; DOI=10.1097/00019606-199712000-00004;
RA   Suzuki A., Ohta S., Shimada M.;
RT   "Gene expression of malignant rhabdoid tumor cell lines by reverse
RT   transcriptase-polymerase chain reaction.";
RL   Diagn. Mol. Pathol. 6:326-332(1997).
//
RX   PubMed=9920784; DOI=10.1006/bbrc.1998.9968;
RA   Mori T., Fukuda Y., Kuroda H., Matsumura T., Ota S., Sugimoto T.,
RA   Nakamura Y., Inazawa J.;
RT   "Cloning and characterization of a novel Rab-family gene, Rab36,
RT   within the region at 22q11.2 that is homozygously deleted in malignant
RT   rhabdoid tumors.";
RL   Biochem. Biophys. Res. Commun. 254:594-600(1999).
//
RX   PubMed=11557780; DOI=10.1038/modpathol.3880401;
RA   Itakura E., Tamiya S., Morita K., Shiratsuchi H., Kinoshita Y.,
RA   Oshiro Y., Oda Y., Ohta S., Furue M., Tsuneyoshi M.;
RT   "Subcellular distribution of cytokeratin and vimentin in malignant
RT   rhabdoid tumor: three-dimensional imaging with confocal laser scanning
RT   microscopy and double immunofluorescence.";
RL   Mod. Pathol. 14:854-861(2001).
//
RX   PubMed=11921280; DOI=10.1002/gcc.10052;
RA   Uno K., Takita J., Yokomori K., Tanaka Y., Ohta S., Shimada H.,
RA   Gilles F.H., Sugita K., Abe S., Sako M., Hashizume K., Hayashi Y.;
RT   "Aberrations of the hSNF5/INI1 gene are restricted to malignant
RT   rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric
RT   solid tumors.";
RL   Genes Chromosomes Cancer 34:33-41(2002).
//
RX   PubMed=12210830; DOI=10.1002/jnr.10330;
RA   Yoshida S., Narita T., Taga T., Ohta S., Takeuchi Y.;
RT   "Malignant rhabdoid tumor shows incomplete neural characteristics as
RT   revealed by expression of SNARE complex.";
RL   J. Neurosci. Res. 69:642-652(2002).
//
RX   PubMed=16557275; DOI=10.1038/modpathol.3800599;
RA   Izumi T., Oda Y., Hasegawa T., Nakanishi Y., Iwasaki H., Sonobe H.,
RA   Goto H., Kusakabe H., Takahira T., Kobayashi C., Kawaguchi K.-i.,
RA   Saito T., Yamamoto H., Tamiya S., Iwamoto Y., Tsuneyoshi M.;
RT   "Prognostic significance of dysadherin expression in epithelioid
RT   sarcoma and its diagnostic utility in distinguishing epithelioid
RT   sarcoma from malignant rhabdoid tumor.";
RL   Mod. Pathol. 19:820-831(2006).
//
RX   PubMed=24418192; DOI=10.1111/cas.12352;
RA   Takita J., Chen Y.-Y., Kato M., Ohki K., Sato Y., Ohta S., Sugita K.,
RA   Nishimura R., Hoshino N., Seki M., Sanada M., Oka A., Hayashi Y.,
RA   Ogawa S.;
RT   "Genome-wide approach to identify second gene targets for malignant
RT   rhabdoid tumors using high-density oligonucleotide microarrays.";
RL   Cancer Sci. 105:258-264(2014).
//
RX   PubMed=31068700; DOI=10.1038/s41586-019-1186-3;
RA   Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C.,
RA   McDonald E.R. III, Barretina J.G., Gelfand E.T., Bielski C.M., Li H.-X.,
RA   Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F.,
RA   Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R.,
RA   Lu Y.-L., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C.,
RA   Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A.,
RA   Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D.,
RA   Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L.,
RA   Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A.,
RA   Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D.,
RA   Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M.,
RA   Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R.,
RA   Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A.,
RA   Sellers W.R.;
RT   "Next-generation characterization of the Cancer Cell Line
RT   Encyclopedia.";
RL   Nature 569:503-508(2019).
//